Human GIMAP4 activation kit by CRISPRa

CAT#: GA110689

GIMAP4 CRISPRa kit - CRISPR gene activation of human GTPase, IMAP family member 4



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
GIMAP4 mouse monoclonal antibody, clone OTI1A11 (formerly 1A11)
    • 100 ul

CNY 1,999.00
CNY 2,700.00


GIMAP4 (Myc-DDK-tagged)-Human GTPase, IMAP family member 4 (GIMAP4)
    • 10 ug

CNY 2,400.00
CNY 3,990.00


purified GIMAP4 biotinylated mouse monoclonal detection antibody, validated for Luminex assays
    • 50 ug

CNY 2,700.00
CNY 3,790.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol GIMAP4
Locus ID 55303
Kit Components

GA110689G1, GIMAP4 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA110689G2, GIMAP4 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA110689G3, GIMAP4 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_018326, NM_001363532
Synonyms IAN-1; IAN1; IMAP4; MSTP062
Summary This gene encodes a protein belonging to the GTP-binding superfamily and to the immuno-associated nucleotide (IAN) subfamily of nucleotide-binding proteins. The encoded protein of this gene may be negatively regulated by T-cell acute lymphocytic leukemia 1 (TAL1). In humans, the IAN subfamily genes are located in a cluster at 7q36.1. [provided by RefSeq, Jul 2008]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...